Have a personal or library account? Click to login
Spectrofluorimetric determination of gemifloxacin mesylate and linezolid in pharmaceutical formulations: Application of quinone-based fluorophores and enhanced native fluorescence Cover

Spectrofluorimetric determination of gemifloxacin mesylate and linezolid in pharmaceutical formulations: Application of quinone-based fluorophores and enhanced native fluorescence

Open Access
|Mar 2014

References

  1. 1. T. L. Lemke, D. A. Williams, V. F. Roche and S. W. Zito, Foye’s Principles of Medicinal Chemistry, 6th ed., Wolters Kluwer, Lippincott Williams & Wilkins, New York 2008.
  2. 2. M. J. O’Neil, P. E. Heckelman, C. B. Koch, K. J. Roman, C. M. Kenny and M. R. D’Arecca, The Merck Index, An Encyclopedia of Chemicals, Drugs and Biologicals, 14th ed., Merck Research Laboratories Division of Merck & Co., Inc., Whitehouse Station (NJ) 2006.
  3. 3. B. A. Moussa, M. A. Mahrouse, M. A. Hassan and M. G. Fawzy, Stability indicating spectrophotometric and TLC densitometric methods for the determination of gemifloxacin mesylate in tablet form, Anal. Chem. Indian J. 12 (2013) 165-176.
  4. 4. C. S. Paim, F. Fuhr, M. Steppe, E. Schapoval and S. Eva, Gemifloxacin mesylate: UV spectrophotometric method for quantitative determination using experimental design for robustness, Quimica Nova. 35 (2012) 193-197; DOI: 10.1590/S0100-40422012000100033.10.1590/S0100-40422012000100033
  5. 5. R. El-Bagary, N. F. Abo-Talib and M. B. N. Eldin, Validated stability indicating assay of gemifloxacin by different chromatographic and spectrophotometric methods of analysis, J. Chem. Pharm. Res. 3 (2011) 562-570.
  6. 6. S. S. Panda, B. V. V. Ravi Kumar, K. S. Rao, V. R. Kumar and D. Patanaik, Difference spectrophotometric determination of gemifloxacin mesylate in tablet formulation, Asian J. Biochem. Pharm. Res. 1 (2011) 442-447; DOI: 10.1002/bio.2347.10.1002/bio.234722362634
  7. 7. K. B. C. Sekhar, D. Madhuri and N. Devanna, Direct and derivative spectrophotometric determination of gemifloxacin mesylate via metal chelate, Acta Cienc. Indica, Ser. Chem. 36 (2010) 165-171.
  8. 8. R. Rote Ambadas and S. P. Pingle, Validated UV-spectrophotometric methods for determination of gemifloxacin mesylate in pharmaceutical tablet dosage forms, E-J. Chem. 7 (Suppl. 1) (2010) S344-S348; DOI: 10.1155/2010/346847.10.1155/2010/346847
  9. 9. D. Madhuri, K. B. Chandrasekhar, N. Devanna and G. Somasekhar, Direct and derivative spectrophotometric determination of gemifloxacin mesylate in pure form and pharmaceutical preparations using p acceptors, Int. J. Pharm. Sci. Res. 1 (2010) 222-230.
  10. 10. Z. Y. Al Shoaibi and A. A. Gouda, Spectrophotometric methods for the determination of gemifloxacin mesylate in pure form and pharmaceutical formulations, Anal. Chem: Indian J. 9 (2010) 129-136.
  11. 11. M. V. Krishna and D. G. Sankar, Utility of s and p-acceptors for the spectrophotometric determination of gemifloxacin mesylate in pharmaceutical formulations, E-J. Chem. 5 (2008) 493-498; DOI: 10.1155/2008/801545.10.1155/2008/801545
  12. 12. S. E. K. Tekkeli and A. Önal, Spectrofluorimetric methods for the determination of gemifloxacin in tablets and spiked plasma samples, J. Fluoresc. 21 (2011) 1001-1007; DOI: 10.1007/s10895-010-0759-1.10.1007/s10895-010-0759-120981565
  13. 13. N. F. Youssef and L. I. Bebawy, Spectrofluorometric methods for the determination of gemifloxacin mesylate and cefamandole nafate in bulk powder and pharmaceutical preparations, Bull. Fac. Pharm. Cairo Univ. 44 (2006) 215-227.
  14. 14. A. A. Elbashir, B. A. Saad, S. M. Abdussalam, K. M. M. Al-Azzam and H. Y. Aboul-Enein, Validated stability indicating assay of gemifloxacin and lomefloxacin in tablet formulations by capillary electrophoresis, J. Liq. Chromatogr. Rel. Tech. 31 (2008) 1465-1477; DOI: 10.1080/10826070802039481.10.1080/10826070802039481
  15. 15. A. R. Rote and S. P. Pingle, Reversed phase-HPLC and HPTLC methods for determination of gemifloxacin mesylate in human plasma, J. Chromatogr. B 877 (2009) 3719-3723; DOI: 10.1016/ j.jchromb.2009.08.013.10.1016/j.jchromb.2009.08.01319716354
  16. 16. D. Nagavalli, G. Abirami and S. K. Kumar, Validated HPLC method for the simultaneous estimation of gemifloxacin mesylate and ambroxol hydrochloride in bulk and tablet dosage form, J. Pharm. Res. 4 (2011) 1701-1703.
  17. 17. J. H. Block and J. M. Beals, Wilson and Grisvold's Textbook of Organic Medicinal and Pharmaeutical Chemistry, 11th ed., Wolters Kluwer, Lippincott Williams & Wilkins, New York 2004.
  18. 18. M. M. Annapurna, K. S. Kumar and M. V. V. S. G. Reddy, New derivative spectrophotometric methods for the determination of linezolid - an antibacterial drug, J. Chem. Pharm. Res. 4 (2012) 714-718.
  19. 19. S. A. Patel, P. U. Patel, N. J. Patel, M. M. Patel and U. V. Bangoriya, High performance thin layer chromatographic method for estimation of linezolid in tablets, Indian J. Pharm. Sci. 69 (2007) 571-574; DOI: 10.4103/0250-474X.36948.10.4103/0250-474X.36948
  20. 20. S. Mohapatra, M. M. Annapurna, B. V. V. Ravi Kumar, M. Anwar, M. H. Warsi and S. Akhter, Validated stability indicating RP-HPLC method for the estimation of linezolid in a pharmaceutical dosage form, J. Liq. Chromatogr. Rel. Tech. 34 (2011) 2185-2195; DOI: 10.1080/10826076. 2011.585548.
  21. 21. L. Vlase, D. Muntean, M. Cuciureanu, R. Cuciureanu and S. Gocan, High-throughput determination of linezolid in human plasma by liquid chromatography tandem mass spectrometry, J. Liq. Chromatogr. Rel. Tech. 34 (2011) 436-445; DOI: 10.1080/10826076.2011.555677.10.1080/10826076.2011.555677
  22. 22. D. Cattaneo, S. Baldelli, F. Conti, V. Cozzi and E. Clementi, Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection, Ther. Drug Monit. 32 (2010) 520-524; DOI: 10.1097/FTD.0b013 e3181d5eeee.
  23. 23. N. M. El-Enany, A. Abdelal and F. Belal, Spectrofluorimetric determination of sertraline in dosage forms and human plasma through derivatization with 9-fluorenylmethyl chloroformate, Chem. Central J. 5 (2011) 56-63; DOI: 10.1186/1752-153X-5-56.10.1186/1752-153X-5-56321280921978386
  24. 24. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Q2 (R1): Validation of Analytical Procedures: Text and Methodology, ICH, Geneva 2005.
  25. 25. D. Liming, X. Qingqin and Y. Jianmei, Fluorescence spectroscopy determination of fluoroquinolones by charge-transfer reaction, J. Pharm. Biomed. Anal. 33 (2003) 693-698; DOI: 10.1016/50731-7085(03)00365-0.
  26. 26. M. F. Abdel Ghany, A. M. El Kosasy, M. F. Ayad and L. E. Abdel Fattah, Spectrophotometric and spectrofluorimetric determination of gentamicin and tobramycin using 1,4-benzoquinone, Bull. Fac. Pharm. Cairo Univ. 41 (2003) 69-88.
  27. 27. S. Sharif, I. U. Khan, T. A. Sheikh, Y. Sharif and M. Ashfaq, Validated stability-indicating HPLC method for analysis of gemifloxacin in tablet formulations, Acta Chromatogr. 41 (2011) 95-107; DOI: 10.1556/AChrom.23.2011.1.6.10.1556/AChrom.23.2011.1.6
  28. 28. J. Li and H. Wu, HPLC determination of linezolid plasma concentration, Chin. J. Mod. Appl. Pharm. 27 (2010) 353-355.
DOI: https://doi.org/10.2478/acph-2014-0005 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 15 - 28
Published on: Mar 25, 2014
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2014 Bahia Abbas Moussa, Marianne Alphonse Mahrouse, Mahmoud Ali Hassan, Michael Gamal Fawzy, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.